The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Is the occurrence of higher adverse effects associated with better oncological outcome in metastatic urothelial carcinoma patients treated with pembrolizumab?
 
Nozomi Hayakawa
No Relationships to Disclose
 
Eiji Kikuchi
Speakers' Bureau - Astellas Pharma; AstraZeneca Japan; Chugai Pharma; MSD K.K; Taiho Pharmaceutical
 
Koichirou Ogihara
No Relationships to Disclose
 
Seiya Hattori
No Relationships to Disclose
 
Shunsuke Yoshimine
No Relationships to Disclose
 
Suguru Shirotake
No Relationships to Disclose
 
Takashi Okabe
No Relationships to Disclose
 
Ryo Yamashita
No Relationships to Disclose
 
Mototsugu Oya
No Relationships to Disclose